Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series.

Carpenter CR, McFarland F, Avidan M, Berger M, Inouye SK, Karlawish J, Lin FR, Marcantonio E, Morris JC, Reuben DB, Shah RC, Whitson HE, Asthana S, Verghese J.

J Am Geriatr Soc. 2019 Aug 22. doi: 10.1111/jgs.16093. [Epub ahead of print]

PMID:
31436318
2.

Authors' reply.

Zhong R, Sisti DA, Karlawish JH.

Br J Psychiatry. 2019 Aug;215(2):502-503. doi: 10.1192/bjp.2019.143. No abstract available.

PMID:
31288882
3.

Is the WHO Definition of Health Aging Well? Frameworks for "Health" After Three Score and Ten.

Fallon CK, Karlawish J.

Am J Public Health. 2019 Aug;109(8):1104-1106. doi: 10.2105/AJPH.2019.305177. No abstract available.

PMID:
31268759
4.

Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias.

Mashour GA, Frank L, Batthyany A, Kolanowski AM, Nahm M, Schulman-Green D, Greyson B, Pakhomov S, Karlawish J, Shah RC.

Alzheimers Dement. 2019 Aug;15(8):1107-1114. doi: 10.1016/j.jalz.2019.04.002. Epub 2019 Jun 19.

5.

Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure".

Grill JD, Cox CG, Harkins K, Karlawish J.

Alzheimers Res Ther. 2019 Jun 4;11(1):51. doi: 10.1186/s13195-019-0504-1. No abstract available.

6.

Attitudes Toward Physician-Assisted Death From Individuals Who Learn They Have an Alzheimer Disease Biomarker.

Largent EA, Terrasse M, Harkins K, Sisti DA, Sankar P, Karlawish J.

JAMA Neurol. 2019 Jul 1;76(7):864-866. doi: 10.1001/jamaneurol.2019.0797. No abstract available.

PMID:
31034041
7.

Social Cognition and the Aging Brain.

Karlawish J.

Ann Intern Med. 2019 May 21;170(10):726-727. doi: 10.7326/M19-0907. Epub 2019 Apr 16. No abstract available.

PMID:
30986825
8.

A pragmatist's guide to the assessment of decision-making capacity.

Zhong R, Sisti DA, Karlawish JH.

Br J Psychiatry. 2019 Apr;214(4):183-185. doi: 10.1192/bjp.2019.17.

PMID:
30896380
9.

Preclinical Alzheimer Disease and the Dawn of the Pre-Caregiver.

Largent EA, Karlawish J.

JAMA Neurol. 2019 Jun 1;76(6):631-632. doi: 10.1001/jamaneurol.2019.0165. No abstract available.

PMID:
30855658
10.

The Interview for Decisional Abilities (IDA): a tool to assess the decisional capacity of abused and neglected older adults.

Abrams RC, Ansell P, Breckman R, Karlawish J, Lachs M, Holt-Knight D, Needell N, Rogers G, LoFaso V.

J Elder Abuse Negl. 2019 Mar;31(3):244-254. doi: 10.1080/08946566.2019.1573392. Epub 2019 Feb 27.

PMID:
30810485
11.

GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.

Langbaum JB, Karlawish J, Roberts JS, Wood EM, Bradbury A, High N, Walsh TL, Gordon D, Aggarwal R, Davis P, Stowell C, Trisko L, Langlois CM, Reiman EM, Tariot PN.

Alzheimers Dement. 2019 Apr;15(4):515-524. doi: 10.1016/j.jalz.2018.12.007. Epub 2019 Feb 13.

PMID:
30772251
12.

"Together Make a Visit; Together Make a Plan": Messaging to Adult Children with Concerns about a Parent's Memory Loss.

Jordan A, Bleakley A, Harkins K, Hailu T, Cassidy K, Hachey S, Karlawish J.

Health Commun. 2019 Feb 1:1-12. doi: 10.1080/10410236.2019.1570428. [Epub ahead of print]

PMID:
30706743
13.

"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".

Jagust W, Jack CR Jr, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Sperling R.

Alzheimers Dement. 2019 Jan;15(1):153-157. doi: 10.1016/j.jalz.2018.11.002. No abstract available.

PMID:
30642435
14.

Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial.

Grill JD, Cox CG, Harkins K, Karlawish J.

Alzheimers Res Ther. 2018 Dec 22;10(1):125. doi: 10.1186/s13195-018-0452-1.

15.

Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Krutsinger DC, McMahon J, Stephens-Shields AJ, Bayes B, Brooks S, Hitsman BL, Lubitz SF, Reyes C, Schnoll RA, Ryan Greysen S, Mercede A, Patel MS, Reale C, Barg F, Karlawish J, Polsky D, Volpp KG, Halpern SD.

Contemp Clin Trials. 2019 Jan;76:1-8. doi: 10.1016/j.cct.2018.11.007. Epub 2018 Nov 8.

PMID:
30414865
16.

Amyloid in the Brain, Alzheimer's on the Mind.

Karlawish J.

Hastings Cent Rep. 2018 Sep;48(5):inside back cover. doi: 10.1002/hast.904.

PMID:
30311197
17.

Study partners: essential collaborators in discovering treatments for Alzheimer's disease.

Largent EA, Karlawish J, Grill JD.

Alzheimers Res Ther. 2018 Sep 27;10(1):101. doi: 10.1186/s13195-018-0425-4.

18.

The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers.

Arias JJ, Tyler AM, Oster BJ, Karlawish J.

J Law Med Ethics. 2018 Jun;46(2):485-498. doi: 10.1177/1073110518782955.

PMID:
30147000
19.

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tröster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D.

NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018. Review.

20.

Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition.

Stites SD, Harkins K, Rubright JD, Karlawish J.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):276-283. doi: 10.1097/WAD.0000000000000262.

PMID:
29944474
21.

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.

Stites SD, Milne R, Karlawish J.

Alzheimers Dement (Amst). 2018 Mar 19;10:285-300. doi: 10.1016/j.dadm.2018.02.006. eCollection 2018. Review.

22.

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors.

Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Review.

23.

What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.

Stites SD, Rubright JD, Karlawish J.

Alzheimers Dement. 2018 Jul;14(7):925-932. doi: 10.1016/j.jalz.2018.01.006. Epub 2018 Mar 27.

24.

Study partners should be required in preclinical Alzheimer's disease trials.

Grill JD, Karlawish J.

Alzheimers Res Ther. 2017 Dec 6;9(1):93. doi: 10.1186/s13195-017-0327-x. Review.

25.

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials.

Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD.

Alzheimers Dement (N Y). 2016 Oct 15;3(1):57-64. doi: 10.1016/j.trci.2016.09.004. eCollection 2017 Jan.

26.

Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.

Mozersky J, Sankar P, Harkins K, Hachey S, Karlawish J.

JAMA Neurol. 2018 Jan 1;75(1):44-50. doi: 10.1001/jamaneurol.2017.2954.

27.

Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.

Courtright KR, Halpern SD, Joffe S, Ellenberg SS, Karlawish J, Madden V, Gabler NB, Szymanski S, Yadav KN, Dember LM.

Trials. 2017 Oct 11;18(1):474. doi: 10.1186/s13063-017-2217-8.

28.

Awareness of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia Diagnoses Associated With Lower Self-Ratings of Quality of Life in Older Adults.

Stites SD, Karlawish J, Harkins K, Rubright JD, Wolk D.

J Gerontol B Psychol Sci Soc Sci. 2017 Oct 1;72(6):974-985. doi: 10.1093/geronb/gbx100.

29.

Prognosis Communication in Late-Life Disability: A Mixed Methods Study.

Wong TW, Lang-Brown S, Romo RD, Au-Yeung A, Lee SJ, Moran PJ, Karlawish J, Sudore R, Clayton J, Smith AK.

J Am Geriatr Soc. 2017 Nov;65(11):2496-2501. doi: 10.1111/jgs.15025. Epub 2017 Sep 14.

30.

Impact of Alzheimer disease patients' sleep disturbances on their caregivers.

Gehrman P, Gooneratne NS, Brewster GS, Richards KC, Karlawish J.

Geriatr Nurs. 2018 Jan - Feb;39(1):60-65. doi: 10.1016/j.gerinurse.2017.06.003. Epub 2017 Jul 3.

31.

Association of Playing High School Football With Cognition and Mental Health Later in Life.

Deshpande SK, Hasegawa RB, Rabinowitz AR, Whyte J, Roan CL, Tabatabaei A, Baiocchi M, Karlawish JH, Master CL, Small DS.

JAMA Neurol. 2017 Aug 1;74(8):909-918. doi: 10.1001/jamaneurol.2017.1317.

32.

Communicating mild cognitive impairment diagnoses with and without amyloid imaging.

Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J.

Alzheimers Res Ther. 2017 May 4;9(1):35. doi: 10.1186/s13195-017-0261-y. Review.

33.

A Typical Day With Mild Cognitive Impairment.

Hailu T, Cannuscio CC, Dupuis R, Karlawish J.

Am J Public Health. 2017 Jun;107(6):927-928. doi: 10.2105/AJPH.2017.303752. Epub 2017 Apr 20. No abstract available.

34.

Parkinsonian signs are a risk factor for falls.

Dahodwala N, Nwadiogbu C, Fitts W, Partridge H, Karlawish J.

Gait Posture. 2017 Jun;55:1-5. doi: 10.1016/j.gaitpost.2017.03.039. Epub 2017 Apr 4.

35.

Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.

Milne R, Karlawish J.

Lancet Psychiatry. 2017 Apr;4(4):e6-e7. doi: 10.1016/S2215-0366(17)30089-5. No abstract available.

36.

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.

Qian J, Wolters FJ, Beiser A, Haan M, Ikram MA, Karlawish J, Langbaum JB, Neuhaus JM, Reiman EM, Roberts JS, Seshadri S, Tariot PN, Woods BM, Betensky RA, Blacker D.

PLoS Med. 2017 Mar 21;14(3):e1002254. doi: 10.1371/journal.pmed.1002254. eCollection 2017 Mar.

37.

Alzheimer's disease: The next frontier-Special Report 2017.

Karlawish J, Jack CR Jr, Rocca WA, Snyder HM, Carrillo MC.

Alzheimers Dement. 2017 Apr;13(4):374-380. doi: 10.1016/j.jalz.2017.02.006. Epub 2017 Mar 14.

PMID:
28314660
38.

A Trial of Financial and Social Incentives to Increase Older Adults' Walking.

Harkins KA, Kullgren JT, Bellamy SL, Karlawish J, Glanz K.

Am J Prev Med. 2017 May;52(5):e123-e130. doi: 10.1016/j.amepre.2016.11.011. Epub 2017 Jan 3.

PMID:
28062271
39.

Identifiable Characteristics and Potentially Malleable Beliefs Predict Stigmatizing Attributions Toward Persons With Alzheimer's Disease Dementia: Results of a Survey of the U.S. General Public.

Stites SD, Johnson R, Harkins K, Sankar P, Xie D, Karlawish J.

Health Commun. 2018 Mar;33(3):264-273. doi: 10.1080/10410236.2016.1255847. Epub 2016 Dec 29.

40.

Patient and Physician Views about Protocolized Dialysis Treatment in Randomized Trials and Clinical Care.

Kraybill A, Dember LM, Joffe S, Karlawish J, Ellenberg SS, Madden V, Halpern SD.

AJOB Empir Bioeth. 2016;7(2):106-115. Epub 2015 Oct 23.

41.

The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of Clinicians.

Zhong Y, Karlawish J, Johnson MK, Neumann PJ, Cohen JT.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):27-33. doi: 10.1097/WAD.0000000000000168.

PMID:
27819845
42.

Unfinished Business in Preventing Alzheimer Disease.

Karlawish J, Langa KM.

JAMA Intern Med. 2016 Dec 1;176(12):1739-1740. doi: 10.1001/jamainternmed.2016.6310. No abstract available.

43.

Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation.

Harhay MN, Hill AS, Wang W, Even-Shoshan O, Mussell AS, Bloom RD, Feldman HI, Karlawish JH, Silber JH, Reese PP.

PLoS One. 2016 Jun 3;11(6):e0156532. doi: 10.1371/journal.pone.0156532. eCollection 2016.

44.

Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Black BS, Taylor HA, Rabins PV, Karlawish J.

Dementia (London). 2016 May 13. pii: 1471301216648796. [Epub ahead of print]

45.

Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.

Rabinovici GD, Karlawish J, Knopman D, Snyder HM, Sperling R, Carrillo MC.

Alzheimers Dement. 2016 Apr;12(4):510-5. doi: 10.1016/j.jalz.2016.03.002.

PMID:
27103054
46.

Acute stroke trials without informed consent: Toward an evidence-based ethical practice.

Karlawish J, Kim SY.

Neurology. 2016 Apr 19;86(16):1472-3. doi: 10.1212/WNL.0000000000002596. Epub 2016 Mar 23. No abstract available.

PMID:
27009260
47.

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.

Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish J.

Alzheimers Dement. 2016 May;12(5):614-22. doi: 10.1016/j.jalz.2016.01.009. Epub 2016 Mar 15.

48.

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.

Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D.

Parkinsonism Relat Disord. 2016 Apr;25:21-6. doi: 10.1016/j.parkreldis.2016.02.020. Epub 2016 Feb 21.

49.

Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.

Grill JD, Zhou Y, Elashoff D, Karlawish J.

Neurobiol Aging. 2016 Mar;39:147-53. doi: 10.1016/j.neurobiolaging.2015.11.007. Epub 2015 Nov 22.

50.

Research consent capacity varies with executive function and memory in Parkinson's disease.

Moelter ST, Weintraub D, Mace L, Cary M, Sullo E, Xie SX, Karlawish J.

Mov Disord. 2016 Mar;31(3):414-7. doi: 10.1002/mds.26469. Epub 2016 Feb 10.

Supplemental Content

Loading ...
Support Center